Follicular Lymphoma Drugs Market - Global Outlook and Forecast 2021-2027

Follicular Lymphoma Drugs Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ746924 | No. of Pages: 90 | Category: Technology
Publisher: Market Monitor Global | Date of Publish: May-2021 
This report contains market size and forecasts of Follicular Lymphoma Drugs in Global, including the following market information:
Global Follicular Lymphoma Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Follicular Lymphoma Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Follicular Lymphoma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Follicular Lymphoma Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Follicular Lymphoma Drugs Market Segment Percentages, By Type, 2020 (%)
Chemotherapy Drug
Monoclonal Antibody
Kinase Inhibitor
CAR T-cell Therapy
Others

China Follicular Lymphoma Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Follicular Lymphoma Drugs Market Segment Percentages, By Application, 2020 (%)
< 55
55-64
65+

Global Follicular Lymphoma Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Follicular Lymphoma Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Follicular Lymphoma Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Follicular Lymphoma Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Genentech (Roche)
Bristol-Myers Squibb
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
Epizyme
Jazz Pharmaceuticals
1 Introduction to Research & Analysis Reports
    1.1 Follicular Lymphoma Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Follicular Lymphoma Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Follicular Lymphoma Drugs Overall Market Size
    2.1 Global Follicular Lymphoma Drugs Market Size: 2021 VS 2027
    2.2 Global Follicular Lymphoma Drugs Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Follicular Lymphoma Drugs Players in Global Market
    3.2 Top Global Follicular Lymphoma Drugs Companies Ranked by Revenue
    3.3 Global Follicular Lymphoma Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Follicular Lymphoma Drugs Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Follicular Lymphoma Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Follicular Lymphoma Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Follicular Lymphoma Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Follicular Lymphoma Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Follicular Lymphoma Drugs Market Size Markets, 2021 & 2027
        4.1.2 Chemotherapy Drug
        4.1.3 Monoclonal Antibody
        4.1.4 Kinase Inhibitor
        4.1.5 CAR T-cell Therapy
        4.1.6 Others
    4.2 By Type - Global Follicular Lymphoma Drugs Revenue & Forecasts
        4.2.1 By Type - Global Follicular Lymphoma Drugs Revenue, 2016-2021
        4.2.2 By Type - Global Follicular Lymphoma Drugs Revenue, 2022-2027
        4.2.3 By Type - Global Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Follicular Lymphoma Drugs Market Size, 2021 & 2027
        5.1.2 < 55
        5.1.3 55-64
        5.1.4 65+
    5.2 By Application - Global Follicular Lymphoma Drugs Revenue & Forecasts
        5.2.1 By Application - Global Follicular Lymphoma Drugs Revenue, 2016-2021
        5.2.2 By Application - Global Follicular Lymphoma Drugs Revenue, 2022-2027
        5.2.3 By Application - Global Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Follicular Lymphoma Drugs Market Size, 2021 & 2027
    6.2 By Region - Global Follicular Lymphoma Drugs Revenue & Forecasts
        6.2.1 By Region - Global Follicular Lymphoma Drugs Revenue, 2016-2021
        6.2.2 By Region - Global Follicular Lymphoma Drugs Revenue, 2022-2027
        6.2.3 By Region - Global Follicular Lymphoma Drugs Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Follicular Lymphoma Drugs Revenue, 2016-2027
        6.3.2 US Follicular Lymphoma Drugs Market Size, 2016-2027
        6.3.3 Canada Follicular Lymphoma Drugs Market Size, 2016-2027
        6.3.4 Mexico Follicular Lymphoma Drugs Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Follicular Lymphoma Drugs Revenue, 2016-2027
        6.4.2 Germany Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.3 France Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.4 U.K. Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.5 Italy Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.6 Russia Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.7 Nordic Countries Follicular Lymphoma Drugs Market Size, 2016-2027
        6.4.8 Benelux Follicular Lymphoma Drugs Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Follicular Lymphoma Drugs Revenue, 2016-2027
        6.5.2 China Follicular Lymphoma Drugs Market Size, 2016-2027
        6.5.3 Japan Follicular Lymphoma Drugs Market Size, 2016-2027
        6.5.4 South Korea Follicular Lymphoma Drugs Market Size, 2016-2027
        6.5.5 Southeast Asia Follicular Lymphoma Drugs Market Size, 2016-2027
        6.5.6 India Follicular Lymphoma Drugs Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Follicular Lymphoma Drugs Revenue, 2016-2027
        6.6.2 Brazil Follicular Lymphoma Drugs Market Size, 2016-2027
        6.6.3 Argentina Follicular Lymphoma Drugs Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Follicular Lymphoma Drugs Revenue, 2016-2027
        6.7.2 Turkey Follicular Lymphoma Drugs Market Size, 2016-2027
        6.7.3 Israel Follicular Lymphoma Drugs Market Size, 2016-2027
        6.7.4 Saudi Arabia Follicular Lymphoma Drugs Market Size, 2016-2027
        6.7.5 UAE Follicular Lymphoma Drugs Market Size, 2016-2027
7 Players Profiles
    7.1 Genentech (Roche)
        7.1.1 Genentech (Roche) Corporate Summary
        7.1.2 Genentech (Roche) Business Overview
        7.1.3 Genentech (Roche) Follicular Lymphoma Drugs Major Product Offerings
        7.1.4 Genentech (Roche) Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.1.5 Genentech (Roche) Key News
    7.2 Bristol-Myers Squibb
        7.2.1 Bristol-Myers Squibb Corporate Summary
        7.2.2 Bristol-Myers Squibb Business Overview
        7.2.3 Bristol-Myers Squibb Follicular Lymphoma Drugs Major Product Offerings
        7.2.4 Bristol-Myers Squibb Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.2.5 Bristol-Myers Squibb Key News
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Corporate Summary
        7.3.2 Gilead Sciences Business Overview
        7.3.3 Gilead Sciences Follicular Lymphoma Drugs Major Product Offerings
        7.3.4 Gilead Sciences Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.3.5 Gilead Sciences Key News
    7.4 TG Therapeutics
        7.4.1 TG Therapeutics Corporate Summary
        7.4.2 TG Therapeutics Business Overview
        7.4.3 TG Therapeutics Follicular Lymphoma Drugs Major Product Offerings
        7.4.4 TG Therapeutics Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.4.5 TG Therapeutics Key News
    7.5 Bayer
        7.5.1 Bayer Corporate Summary
        7.5.2 Bayer Business Overview
        7.5.3 Bayer Follicular Lymphoma Drugs Major Product Offerings
        7.5.4 Bayer Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.5.5 Bayer Key News
    7.6 Secura Bio
        7.6.1 Secura Bio Corporate Summary
        7.6.2 Secura Bio Business Overview
        7.6.3 Secura Bio Follicular Lymphoma Drugs Major Product Offerings
        7.6.4 Secura Bio Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.6.5 Secura Bio Key News
    7.7 Epizyme
        7.7.1 Epizyme Corporate Summary
        7.7.2 Epizyme Business Overview
        7.7.3 Epizyme Follicular Lymphoma Drugs Major Product Offerings
        7.4.4 Epizyme Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.7.5 Epizyme Key News
    7.8 Jazz Pharmaceuticals
        7.8.1 Jazz Pharmaceuticals Corporate Summary
        7.8.2 Jazz Pharmaceuticals Business Overview
        7.8.3 Jazz Pharmaceuticals Follicular Lymphoma Drugs Major Product Offerings
        7.8.4 Jazz Pharmaceuticals Follicular Lymphoma Drugs Revenue in Global (2016-2021)
        7.8.5 Jazz Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com